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Abstract We purified and characterized an unusual antimicro- 
bial peptide, prophenin-1 (PF-I), from porcine leukocytes. The 
peptide had a mass of 8,683 and contained 79 residues, including 
42 (53.2%) prolines and 15 (19.0%) phenylalanines. Its N-termi- 
nal 60 residues consisted of three perfect and three nearly perfect 
repeats of a decamer, FPPPNFPGPR. Prophenin-I was encoded 
on a cathelin-containing precursor and showed substantially more 
activity against E. coli, a Gram-negative bacterium, than against 
Listeria monocytogenes, a Gram-positive organism, in vitro. 
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I. Introduction 
Endogenous antimicrobial peptides play important roles in 
host defense against microbial infection [1]. Although these 
peptides how marked diversity in structure and antimicrobial 
spectrum, the precursors of many antibiotic peptides of porcine 
[2 6], bovine [7-10] and rabbit [11,12] origin contain a highly 
conserved preproregion that is homologous to cathelin, a puta- 
tive cysteine-proteinase inhibitor originally isolated from pig 
leukocytes [13,14]. Several of these cathelin-associated peptides 
have been isolated and characterized, including porcine PR-39 
[15] and protegrins PG-1, 2 and 3 [16]; bovine Bac 5 [17,18], 
indolicidin 9 [19] and cyclic dodecapeptide [20]; and rabbit p15 
[12] and CAP 18 [11]. Others such as porcine PMAP-36 [5], 
PMAP-23 [6] and PG-4 have been prepared for study by 
chemical synthesis based on sequence translations from cloned 
cDNA. 
We recently purified a remarkable proline and phenylalan- 
ine-rich antimicrobial peptide, 'prophenin-1 ', from porcine leu- 
kocytes. Its characterization, primary sequence, antimicrobial 
activity and relationship to the constellation of cathelin-associ- 
ated antibiotics are described below. 
2. Materials and methods 
2.5 x 117 cm BioGel P-10 column. Prophenin-1 (PF-I) and several 
closely related molecules ('Prophenin-2') emerged at an elution volumn 
of ~ 250-284 ml (43.6~9.4% of column bed volume) and were concen- 
trated for subsequent purification. 
2.2. Purification and antimicrobial testing oJprophenins 
Concentrated prophenin containing fractions were subjected to re- 
versed phase (RP)-HPLC purification on a 4.6 × 250 mm Vydac C18 
column using a linear gradient of acetonitrile that contained 0.1% 
trifluoroacetic acid and increased in acetonitrile by 1% min -~. HPLC 
fractions were tested for antimicrobial ctivities against E. coli ML-35, 
L. monocytogenes, strain EGD and C. albicans train 820 by previously 
described gel overlay and radial diffusion techniques [21]. Further puri- 
fication involved preparative continuous acid urea gel electrophoresis 
elution [22] followed by RP-HPLC. 
2.3. Biochemical nalysis' 
Tricine-SDS-PAGE [23] and AU-PAGE [24] were performed inmini- 
gel formats. Amino acid composition was determined by the Picotag 
technique [25]. Approximately 1 nmol of each prophenin was sequenced 
(Porton 2090 sequencer). Peptide concentration was determined by 
amino acid analysis, bicinchoninic acid [26] 'BCA' protein assay rea- 
gent (Pierce Chemical Co., Rockford, I1), and by the spectrophotomet- 
ric method (AzJA225) of Waddell [27]. 
Approximately 2 nmol of Prophenin-1 was digested with TPCK 
trypsin (enzyme/substrate mass ratio of 1150) in 20 /.tl of 0.1 M 
NH4HCO~ , pH 8.15 at 37°C for 4 hours. Digestion was quenched by 
addition of glacial HOAc (final 25% v/v). After removing an aliquot (50 
pmol) for LC-Electrospray Mass Spectrometric (LC-ES1-MS) meas- 
urement, the digest was dried, and redissolved in 0.1% TFA for RP- 
HPLC purification. The amino acid composition of each peak was 
determined, and the peak that corresponded to C-terminal fragment 
was also sequenced. Similar digestion conditions were used later to 
generate large amount of tryptic fragments for biological functional 
studies. 
2.4. LC-ESI-MS 
LC-mass spectrometric measurements were performed at the mass 
spectrometry core facility at the Beckman Research Institute of the 
Coty of Hope (Duarte, CA) on a quadrupole TSQ-700 mass spectrom- 
eter (Finnigan-MAT, San Jose, CA) equipped with an electrospray ion 
source operating at atmospheric pressure, as reported previously [28]. 
Mass scans were acquired every three seconds in a mass range from 
500-2,000 and the data collection was monitored using both base peak 
and the reconstructed ion current profile. Spectra were generated by 
averaging the scans containing the peak, and the mass assignments were 
made using the Finnigan MAT BIOMASS data reduction software. 
2.1. Preparation of acid extracts of porcine leukocytes and size exclusion 
chromatography 
An acid extract of porcine leukocytes was prepared and ultrafiltered 
through a YM-5 filter as previously described [16]. The filtrate was 
concentrated and subjected to size exclusion chromatography on a 
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3. Results 
3.1, Purification of prophenins 
Prophenins were eluted at 48% acetonitrile on RP-HPLC, 
and were shown to contain at least two major components on 
AU-PAGE.  The more cationic band was named 'Prophenin-l ' ,  
the other was named 'Prophenin-2'. They were subsequently 
purified by preparative continuous acid urea PAGE followed 
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Fig. 1. Polyacrylamide g l electrophoresis ofprophenins. (A) Coomas- 
sie blue stained AU-PAGE (12.5%): lane 1, ~ 30 pg of porcine leukocyte 
acid extract; lane 2, YM-5 filtrate, ~ 15 ¢tg; lane 3, pooled P-10 column 
fractions that contained prophenins, -5/tg; lane 4, prophenin-l, 1/tg; 
lane 5, prophenin-2, 1/~g. (B) Silver stained tricine SDS-PAGE (16.5%): 
lane 1, prophenin-1, //g; lane 2, prophenin-2, 1 ug. 
by desalting on C 18 RP-HPLC, and appeared homogeneous by 
acid urea (AU)-PAGE on 12.5% acrylamide gels and by SDS- 
PAGE on 16.5% acrylamide gels (Fig. 1). 
3.2. Biochemical characterization 
The name prophenin was selected to reflect he abundance of 
proline (57.1%) and phenylalanine (19.0%) residues found by 
amino acid analysis of the purified peptide, as shown in Table 
1. Primary sequence analysis of 1 nmol of Prophenin-1 was 
conducted with an initial yield of 57.6%, and a repetitive yield 
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Fig. 2. Amino acid sequence of prophenin-l. The mature peptide se- 
quence was determined by a combination ofautomated Edman degra- 
dation, tryptic mapping and direct LC-ESI-MS analysis of the tryptic 
digest. Res. 78 and 79 were assigned based on mass difference. The 
sequence was confirmed by cDNA cloning ([3% Zhao et al., unpub- 
lished). The conserved residues in the polydecameric portion of the 
molecule are shaded. The trypsin cleavage sites are indicated by double 
underlining. 
of 95.98%. Remarkably, this provided unambiguous identifica- 
tion of all but 3 of the first 65 residues (residues 51, 58 and 61) 
shown in Fig. 2. A related peptide, 'Prophenin-2', showed 
slightly slower migration on AU-PAGE gels (Fig. 1) and had 
a similar composition on amino acid analysis (data not shown). 
However, since at least two residues were seen at each sequence 
cycle, we failed to obtain a definitive sequence for this peptide 
mixture. 
The tryptic digest of Prophenin-1 eluted as three broad peaks 
(Fig. 3), which we designated as Fragments 1, 2 and 3 in the 
order of their elution from the column. Amino acid composi- 
tion analysis (Table 1) indicated that fragment 1 represented 
residues 1-11, fragment 2 represented residues 12-21. The inte- 
grated area of fragment 2 was -3  times greater that of fragment 
1 (results not shown), consistent with the initial sequence data 
shown in Fig. 2 which demonstrates 3 exact repeats of this motif 
between residues 12 and 41. Fragment 3, which contained an 
Ile residue and two additional Arg residues, therefore repre- 
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Fig. 3. RP-HPLC purification of prophenin-1 tryptic digest. Approximately 10 nmol of the digest was purified on a 4.6 x 250 mm Vydac C18 column 
using a linear gradient of acetonitrile that contained 0.1% TFA and increased in acetonitrile concentration by 1% per min. 
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Fig. 4. Deconvoluted mass spectra of prophenin-1 tryptic fragments 
obtained uring direct LC-ESI-MS analysis of ~ 30 pmol of tryptic di- 
gest. The main figure shows tryptic fragment 1(F1). The insets how 
tryptic fragments 2 (F2) and 3 (F3). 
sented residue 42 to nearby the C terminus. Microsequencing 
of Fragment 3 provided sequence data through residue 76, 
showing the presence of Arg at residue 69 followed by a proline. 
Another Arg was assigned at residue 77 based on the amino 
acid composition of this fragment, and was confirmed later by 
mass measurements of this fragment. 
3.3. LC-ESI-MS analyses 
LC-ESI-MS measurement yielded an average mass value of 
8,683.0 for Prophenin-1. When 'Prophenin-2' was similarly ex- 
amined (data not shown), we discerned the presence of at least 
two closely related peptides with average mass values of 8,807.0 
and 8,794.0. 
We subjected 30 pmol of Prophenin-1 tryptic digest to LC- 
ESI-MS analysis, and obtained three broad peaks in both the 
base peak and the reconstructed ion current profiles of the mass 
scan (data not shown). The reconstructed ion current profile 
appeared almost identical to RP-HPLC chromatogram (Fig. 3) 
during purification of the digestion mixture. The deconvoluted 
mass spectra for each tryptic fragment are shown in Fig. 4. 
Fragment 1, 2, and 3 had average mass values of 1,148.0, 
1,125.0 and 3,986.0, respectively. These values agreed with the 
sequence assignments up to residue 77. In addition to 1,148.0, 
a mass value of 1,077.0 was also seen in the deconvoluted mass 
spectrum of fragment 1. The difference (71 mass units) was 
most likely due to the presence of des-ala PF-I, resulting from 
enzymatic (elastase-mediated?) cleavage after the peptide's ol- 
itary alanine residue at position 1. This was also reflected by 
the slightly lower value of alanine in the amino acid composi- 
tion of this fragment (Table 1). 
The calculated average mass for res. 1-77 is 8,437.01,245.99 
mass units smaller than measured mass (8,683.0) of Prophenin- 
1. This mass difference strongly suggests another Pro and Phe 
on the C-terminus of this peptide. This dipeptide, generated 
during trypsin digestion, would not have been easily recovered 
during RP-HPLC purification of the tryptic digest. The order 
Phe78-Pro 79 was assigned based on the successful cleavage after 
Arg 77 by trypsin, since proteolytic enzymes are often cryptic if 
the specific cleavage sites are immediately followed by a proline 
residue. 
3.4. Quantitation of prophen&-I 
PF-1 showed anomalous behavior in two commonly used 
methods for measuring protein concentration. When tested in 
the BCA assay, it failed to generate any color development. The 
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Fig. 5. Antimicrobial activity of purified prophenin-1. Purified prophenin-1 and rabbit defensin NP-1 were tested against E. coli ML-35p and 
L. rnonocytogenes EGD under low (solid symbols) and high (open symbols) ionic strength conditions by radial diffusion assay. Low ionic strength 
conditions were obtained by preparing underlay gels that contained 1% agarose+0.3 mg/ml trypticase soy broth powder in 10 mM sodium phosphate 
buffer (pH 7.4), and high ionic strength conditions were obtained by supplementing this underlay agar with 0.1 M NaCI. Concentrations ofboth 
peptides were determined by amino acid analysis. 
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Fig. 6. Hydropathic index of prophenin-1. Computation was done using an interval of 7 amino acids. Note the unusual repetetive pattern of the 
molecule's N-terminal half. 
spectrophotometric method of A2~5/A2~ 5 consistently gave val- 
ues that were ~4.5 × higher than the values we obtained by 
amino acid analysis, using isoleucine as an internal standard. 
3.5. Antimicrobial activities 
PF-1 demonstrated potent bactericidal activity against Esche- 
richia coli ML-35, but showed little activity against L. monocy- 
togenes and was inactive against C. albicans. As shown in Fig. 
5, its activity against E. coli resembled that of NP-1, a potent 
defensin [29] produced by rabbit leukocytes. Prophenin tryptic 
fragments F1 and F2 were inactive against E. coli at concentra- 
tions up to 500/2g/ml while F3 retained partial microbicidal 
activity at >125/.tg/ml (data not shown). 
4. Discussion 
We were able to establish the first 77 residues equence of the 
mature prophenin-1 by a combination of biochemical tech- 
niques: direct microsequencing, tryptic peptide mapping and 
direct LC-ESI-MS analysis of the tryptic digest. The last two 
C-terminal residues, Phe and Pro, were assigned based on the 
mass difference, and was confirmed by the deduced amino acid 
sequence of clone 12 which we have independently confirmed 
Table 1 
Amino acid composition of Prophenin-1 (PF-1) and its tryptic fragments 
by PCR cloning of bone marrow and genomic DNA (data not 
shown). 
Pungercar et al. [30] recently obtained from porcine bone 
marrow and sequenced two cDNA clones, C12 and C6, that 
encoded virtually identical proline and arginine rich antimicro- 
bial peptides at the C-terminus of a cathelin-containing pre- 
propeptide. The translated sequence of clone C 12 included a 30 
residue, N-terminal signal peptide followed by a 198 residue 
protein whose N-terminal region was 84% identical to porcine 
cathelin in primary sequence. The C-terminal half was noted 
to be rich in proline, arginine and phenylalanine r sidues and 
to show similarities to a previously isolated Pro-Arg rich group 
of antimicrobial peptides, including porcine PR-39 and bovine 
bactenecins, Bac 5 and Bac 7. The prophenin-1 peptide se- 
quence reported in this paper is nearly identical to the C- 
terminal 79 residue stretch near the C-terminus of clone 12, 
except for the Phe for Val substitution at residue 17 of the 
mature peptide which corresponds to the residue present in 
their incompletely sequenced clone 6. 
The sequence of mature prophenin-1 indicates that its pre- 
cursor undergoes cleavage after the glutamine residue (res. # 
144 as per Pungercar) rather than only at the # 126 valine 
residue postulated by Pungercar et al., which otherwise would 
Amino acid PF-1 PF-1 Fragment I Fragment 2 Fragment 3
mol % obs. (seq.) Residues obs. (seq.) Residues obs. (seq.) Residues obs. (seq.) Residues obs. (seq.) 
Asx 5.9 (6.3) 4.6 (5) 0.9 (1) 1.0 (1) 1.4 (1) 
Glx 0.0 (0.0) 0.0 (0) 0.1 (0) 0.0 (0) 0.3 (0) 
Ser 0.0 (0.0) 0.0 (0) 0.1 (0) 0.0 (0) 0.3 (0) 
Gly 9.4 (8.9) 7.3 (7) 1.1 (1) 1.1 (1) 3.5 (3) 
Arg 9.0 (7.6) 7.0 (6) 1.1 (1) 1.1 (1) 2.2 (2) 
Ala 1.1 (1.3) 0.9 (1) 0.6 (1) 0.0 (0) 0.3 (0) 
Pro 57.1 (53.2) 44.5 (42) 5.0 (5) 4.9 (5) 20.3 (21) 
Val 1.4 (1.3) 1.1 (1) 0.9 (1) 0.0 (0) 0.0 (0) 
lie 0.9 (1.3) 0.7 (1) 0.0 (0) 0.0 (0) 0.8 (1) 
Phe 15.2 (19.0) 11.9 (15) 1.2 (1) 1.9 (2) 5.9 (7) 
Trp N.D. (1.3) N.D. (1) N.D. (0) N.D. (0) N.D. (1) 
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result in a 100 amino-acid mature peptide, instead of the 79 
residue peptide described herein. Pungercar's prediction was 
based on the observation that post-translational processing to 
the final mature form of other cathelin associated antimicrobial 
peptides, such as bovine indolicidin [7] and Bac 5 [9], often 
involved cleavage after the valine residue. It remains to be 
determined if post-translational processing of the PF-1 precur- 
sor results in the liberation of an intact arginine and trypto- 
phan-rich 18-mer (RRFPWWWPFLRRPRLRRQ), or if these 
residues are released by piecemeal hydrolytic steps. The other 
difference between the mature PF-1 peptide and the structure 
predicted by Pungercar et al is found at the C-terminus, where 
the last three residues (GRR) are removed. The presence of 
GIy-X-X (X = basic amino acid) sequence at the carboxyl ends 
of many precursors to amidated peptides has been identified as 
the universal combined amidation/proteolytic cleavage recogni- 
tion site [31]. Therefore, prophenin-1 most likely also exists as 
the amidated form, as do several other cathelin-encoded pep- 
tides of porcine (protegrin and PR-39) and bovine leukocytes 
(indolicidin). 
The prophenin-I peptide sequence is remarkable for the 
5 nearly perfect tandem repeats of a proline-rich decamer, 
FPPPNFPGPR. The fidelity of this repetitive motif is broken 
only by the conservative substitution ofVal for Phe in decamer 
1 and by the substitution of Pro 5~ for Arg 5~ at the end of the 
fifth decamer. The latter substitution marks the beginning of 
the peptide's only relatively hydrophobic domain, evident in the 
hydropathy plot shown in Fig. 6. The functional significance 
of the proline-rich tandem repeats and the hydrophobic domain 
are currently under investigation, and will be reported in a later 
communication. 
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